chr14-58450697-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001329943.3(KIAA0586):āc.1080G>Cā(p.Arg360Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,609,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001329943.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIAA0586 | NM_001329943.3 | c.1080G>C | p.Arg360Ser | missense_variant | 8/31 | ENST00000652326.2 | NP_001316872.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA0586 | ENST00000652326.2 | c.1080G>C | p.Arg360Ser | missense_variant | 8/31 | NM_001329943.3 | ENSP00000498929.1 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152044Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000887 AC: 22AN: 247888Hom.: 0 AF XY: 0.0000595 AC XY: 8AN XY: 134560
GnomAD4 exome AF: 0.000119 AC: 174AN: 1456962Hom.: 0 Cov.: 29 AF XY: 0.000119 AC XY: 86AN XY: 725042
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152044Hom.: 0 Cov.: 33 AF XY: 0.0000943 AC XY: 7AN XY: 74270
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 15, 2023 | The c.1080G>C (p.R360S) alteration is located in exon 8 (coding exon 8) of the KIAA0586 gene. This alteration results from a G to C substitution at nucleotide position 1080, causing the arginine (R) at amino acid position 360 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 29, 2017 | The R413S variant in the KIAA0586 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The R413S variant is not observed in the homozygous state or at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R413S variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret R413S as a variant of uncertain significance. - |
Joubert syndrome 23;C4225286:Short-rib thoracic dysplasia 14 with polydactyly Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 08, 2022 | This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 413 of the KIAA0586 protein (p.Arg413Ser). This variant is present in population databases (rs200094677, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with KIAA0586-related conditions. ClinVar contains an entry for this variant (Variation ID: 432994). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Joubert syndrome 23 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 11, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at